DSGN logo

Design Therapeutics, Inc. Common Stock


DSGN: Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations.


Show DSGN Financials

Consumer Interest
SEC Filings

Recent trades of DSGN by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by DSGN's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of DSGN in WallStreetBets Daily Discussion


Recent insights relating to DSGN

CNBC Recommendations

Recent picks made for DSGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DSGN

Corporate Flights

Flights by private jets registered to DSGN